Allergan plans to expand its gastrointestinal research and development (R&D) pipeline and strengthen its position in non-alcoholic steatohepatitis through the acquisition of Tobira Therapeutics.
The company expects to complete the transaction by October 2016 at a cost of up to $1.6bn.
Cannabis Care Canada Inc has announced its acquirement of Mettrum Ltd from Mettrum Health Corporation for a purchase consideration of $5.3m.
Covington & Burling is acting as the legal advisor, while Centerview Partners and Citigroup Inc are acting as financial advisors to Allergan. SKadden, Arps, Slate, Meagher & Flom and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian are acting as legal advisors to Tobira Therapuetics.
Cannabis Care Canada Inc has announced its acquirement of Mettrum Ltd from Mettrum Health Corporation for a purchase consideration of $5.3m.
Pursuant to the acquisition, Mettrum will become a wholly owned subsidiary of CCC and will be renamed as Starseed Medicinal Inc.

US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe acquisition will allow Cannabis Care Canada to make cannabis treatment accessible to all of its members and their families.